Crinetics Pharmaceuticals Cut to Perform From Outperform by Oppenheimer
Dow Jones Newswires
Crinetics Pharmaceuticals Cut to Perform From Outperform by Oppenheimer
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:CRNX
- Language
- English